These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 37836411)

  • 1. Sclerostin, Osteocytes, and Wnt Signaling in Pediatric Renal Osteodystrophy.
    Laster M; Pereira RC; Noche K; Gales B; Salusky IB; Albrecht LV
    Nutrients; 2023 Sep; 15(19):. PubMed ID: 37836411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repression of osteocyte Wnt/β-catenin signaling is an early event in the progression of renal osteodystrophy.
    Sabbagh Y; Graciolli FG; O'Brien S; Tang W; dos Reis LM; Ryan S; Phillips L; Boulanger J; Song W; Bracken C; Liu S; Ledbetter S; Dechow P; Canziani ME; Carvalho AB; Jorgetti V; Moyses RM; Schiavi SC
    J Bone Miner Res; 2012 Aug; 27(8):1757-72. PubMed ID: 22492547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The complexity of chronic kidney disease-mineral and bone disorder across stages of chronic kidney disease.
    Graciolli FG; Neves KR; Barreto F; Barreto DV; Dos Reis LM; Canziani ME; Sabbagh Y; Carvalho AB; Jorgetti V; Elias RM; Schiavi S; Moysés RMA
    Kidney Int; 2017 Jun; 91(6):1436-1446. PubMed ID: 28318623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sclerostin, Osteocytes, and Chronic Kidney Disease - Mineral Bone Disorder.
    Moysés RM; Schiavi SC
    Semin Dial; 2015; 28(6):578-86. PubMed ID: 26288182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exercise Alleviates Osteoporosis in Rats with Mild Chronic Kidney Disease by Decreasing Sclerostin Production.
    Liao HW; Huang TH; Chang YH; Liou HH; Chou YH; Sue YM; Hung PH; Chang YT; Ho PC; Tsai KJ
    Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31027235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating levels of sclerostin but not DKK1 associate with laboratory parameters of CKD-MBD.
    Behets GJ; Viaene L; Meijers B; Blocki F; Brandenburg VM; Verhulst A; D'Haese PC; Evenepoel P
    PLoS One; 2017; 12(5):e0176411. PubMed ID: 28493902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. From skeletal to cardiovascular disease in 12 steps-the evolution of sclerostin as a major player in CKD-MBD.
    Brandenburg VM; D'Haese P; Deck A; Mekahli D; Meijers B; Neven E; Evenepoel P
    Pediatr Nephrol; 2016 Feb; 31(2):195-206. PubMed ID: 25735207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Turning over renal osteodystrophy dogma: direct actions of FGF23 on osteoblast β-catenin pathway.
    Schiavi SC; Moysés RM
    Kidney Int; 2016 Jul; 90(1):17-20. PubMed ID: 27312441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The WNT/β-catenin system in chronic kidney disease-mineral bone disorder syndrome.
    Zhang L; Adu IK; Zhang H; Wang J
    Int Urol Nephrol; 2023 Oct; 55(10):2527-2538. PubMed ID: 36964322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FGF-23 and sclerostin in serum and bone of CKD patients.
    Lima F; Monier-Faugere MC; Mawad H; David V; Malluche HH
    Clin Nephrol; 2023 May; 99(5):209-218. PubMed ID: 36970967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sclerostin: a new biomarker of CKD-MBD.
    Figurek A; Rroji M; Spasovski G
    Int Urol Nephrol; 2020 Jan; 52(1):107-113. PubMed ID: 31612420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of Serum Sclerostin with Bone Sclerostin in Chronic Kidney Disease is Lost in Glucocorticoid Treated Patients.
    Boltenstål H; Qureshi AR; Behets GJ; Lindholm B; Stenvinkel P; D'Haese PC; Haarhaus M
    Calcif Tissue Int; 2019 Feb; 104(2):214-223. PubMed ID: 30406279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disturbances of Wnt/β-catenin pathway and energy metabolism in early CKD: effect of phosphate binders.
    de Oliveira RB; Graciolli FG; dos Reis LM; Cancela AL; Cuppari L; Canziani ME; Carvalho AB; Jorgetti V; Moysés RM
    Nephrol Dial Transplant; 2013 Oct; 28(10):2510-7. PubMed ID: 23975746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Osteocytic Sclerostin Expression as an Indicator of Altered Bone Turnover.
    Huybrechts Y; Evenepoel P; Haarhaus M; Cavalier E; Dams G; Van Hul W; D'Haese PC; Verhulst A
    Nutrients; 2023 Jan; 15(3):. PubMed ID: 36771305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sclerostin and Dickkopf-1 in renal osteodystrophy.
    Cejka D; Herberth J; Branscum AJ; Fardo DW; Monier-Faugere MC; Diarra D; Haas M; Malluche HH
    Clin J Am Soc Nephrol; 2011 Apr; 6(4):877-82. PubMed ID: 21164019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating Levels of Dickkopf-Related Protein 1 Decrease as Measured GFR Declines and Are Associated with PTH Levels.
    Forster CM; White CA; Turner ME; Norman PA; Ward EC; Hopman WM; Adams MA; Holden RM
    Am J Nephrol; 2020; 51(11):871-880. PubMed ID: 33238271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of TGF-β in a mouse model of high turnover renal osteodystrophy.
    Liu S; Song W; Boulanger JH; Tang W; Sabbagh Y; Kelley B; Gotschall R; Ryan S; Phillips L; Malley K; Cao X; Xia TH; Zhen G; Cao X; Ling H; Dechow PC; Bellido TM; Ledbetter SR; Schiavi SC
    J Bone Miner Res; 2014; 29(5):1141-57. PubMed ID: 24166835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unraveling the osteocyte in CKD-MBD post-renal transplantation.
    Laster M; Pereira RC; Salusky IB
    Kidney Int; 2019 Nov; 96(5):1059-1061. PubMed ID: 31648693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sclerostin in chronic kidney disease-mineral bone disorder think first before you block it!
    Brandenburg VM; Verhulst A; Babler A; D'Haese PC; Evenepoel P; Kaesler N
    Nephrol Dial Transplant; 2019 Mar; 34(3):408-414. PubMed ID: 29846712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impaired osteocyte maturation in the pathogenesis of renal osteodystrophy.
    Pereira RC; Salusky IB; Roschger P; Klaushofer K; Yadin O; Freymiller EG; Bowen R; Delany AM; Fratzl-Zelman N; Wesseling-Perry K
    Kidney Int; 2018 Nov; 94(5):1002-1012. PubMed ID: 30348285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.